We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$6.05B
AUM Growth
-$355M
Cap. Flow
-$238M
Cap. Flow %
-3.93%
Top 10 Hldgs %
22.18%
Holding
314
New
46
Increased
155
Reduced
70
Closed
36

Top Buys

Rank Stock Value
1
WGS icon
GeneDx Holdings
WGS
+$41.9M
2
GNRC icon
Generac Holdings
GNRC
+$40.9M
3
PCVX icon
Vaxcyte
PCVX
+$24.8M
4
TER icon
Teradyne
TER
+$24.8M
5
ULS icon
UL Solutions
ULS
+$21.1M

Top Sells

Rank Stock Value
1
MIRM icon
Mirum Pharmaceuticals
MIRM
+$64.4M
2
GEV icon
GE Vernova
GEV
+$42.1M
3
INSP icon
Inspire Medical Systems
INSP
+$40.6M
4
RNAM
Avidity Biosciences
RNAM
+$37.8M
5
LAD icon
Lithia Motors
LAD
+$33.8M

Sector Composition

Rank Sector Weight
1 Healthcare 39.12%
2 Industrials 19.41%
3 Technology 15.63%
4 Energy 7.14%
5 Consumer Discretionary 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROL icon
51
Rollins
ROL
$17.4B
$40.2M 0.67%
753,499
+13,753
+2% +$818K
ESI icon
52
Element Solutions
ESI
$8.95B
$39.8M 0.66%
1,171,467
+22,321
+2% +$699K
FERG icon
53
Ferguson
FERG
$44.8B
$39.3M 0.65%
169,460
+1,185
+0.7% +$288K
HBAN icon
54
Huntington Bancshares
HBAN
$34.2B
$39.3M 0.65%
2,533,502
-7,159
-0.3% -$122K
CHWY icon
55
Chewy
CHWY
$9.56B
$38.1M 0.63%
1,412,290
-427
-0% -$11.9K
TER icon
56
Teradyne
TER
$57.2B
$37.6M 0.62%
127,466
+88,834
+230% +$24.8M
GLBE icon
57
Global E Online
GLBE
$6.59B
$37.6M 0.62%
1,218,345
+656
+0.1% +$23.1K
TLN
58
Talen Energy Corp
TLN
$14.6B
$37.4M 0.62%
117,183
-7,413
-6% -$2.62M
FAST icon
59
Fastenal
FAST
$58.1B
$36.9M 0.61%
797,585
+19,919
+3% +$894K
ABVX
60
Abivax
ABVX
$10B
$35.7M 0.59%
320,576
-7,335
-2% -$868K
ROP icon
61
Roper Technologies
ROP
$42B
$33.8M 0.56%
95,661
-88,505
-48% -$32.7M
HLI icon
62
Houlihan Lokey
HLI
$9.24B
$33.8M 0.56%
236,136
+1,732
+0.7% +$285K
CLDX icon
63
Celldex Therapeutics
CLDX
$3.16B
$32.9M 0.54%
1,037,000
-605,559
-37% -$16.5M
BBIO icon
64
BridgeBio Pharma
BBIO
$15.4B
$32.5M 0.54%
437,130
+75,000
+21% +$5.44M
AIT icon
65
Applied Industrial Technologies
AIT
$12B
$32.1M 0.53%
121,287
+1,952
+2% +$531K
CYTK icon
66
Cytokinetics
CYTK
$10.3B
$31.6M 0.52%
479,098
-513
-0.1% -$32.6K
TRVI icon
67
Trevi Therapeutics
TRVI
$2.43B
$31.3M 0.52%
2,622,306
– –
DXCM icon
68
DexCom
DXCM
$34B
$31.1M 0.51%
495,003
+20,693
+4% +$1.44M
AXON
69
Axon Enterprise
AXON
$49.3B
$29.6M 0.49%
69,843
-859
-1% -$446K
WGS icon
70
GeneDx Holdings
WGS
$2.63B
$29.5M 0.49%
+459,015
New +$41.9M
PVLA
71
Palvella Therapeutics
PVLA
$2.18B
$29M 0.48%
233,248
+131,500
+129% +$13.7M
KMTS
72
Kestra Medical Technologies
KMTS
$1.51B
$28.8M 0.48%
1,445,864
+176,213
+14% +$4.15M
DDOG icon
73
Datadog
DDOG
$85.9B
$28.3M 0.47%
239,835
+919
+0.4% +$113K
CELC icon
74
Celcuity
CELC
$4.41B
$27.8M 0.46%
243,899
-69,780
-22% -$7.61M
EVMN
75
Evommune Inc
EVMN
$487M
$27.8M 0.46%
1,209,129
+247,604
+26% +$5.6M
1 2
3
4 5

Similar funds

S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.41B AUM 26.32% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Eventide Asset Management's Q1 2026 Portfolio in Review

As of Q1 2026, Eventide Asset Management held 314 positions worth $6.05B, down 5.5% from $6.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Eventide Asset Management withdrew a net $238M in Q1 2026, closing 36 positions and reducing 70 holdings. Its most notable exit was Inspire Medical Systems, an estimated $40.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 42% a quarter earlier, followed by Industrials and Technology.

Against the trend, Eventide Asset Management opened a new position in GeneDx Holdings worth $29.5M.

  • Eventide Asset Management's largest Q1 2026 buy was GeneDx Holdings: 459,015 shares worth $29.5M.
  • Eventide Asset Management added most to Generac Holdings in Q1 2026, an estimated $40.9M increase.
  • Eventide Asset Management's biggest Q1 2026 reduction was Mirum Pharmaceuticals, cutting an estimated $64.4M.
  • Eventide Asset Management fully exited Inspire Medical Systems in Q1 2026, selling an estimated $40.6M.
  • Eventide Asset Management's ten largest holdings make up 22% of its $6.05B portfolio in Q1 2026.
  • Eventide Asset Management opened 46 new positions and closed 36 in Q1 2026.
  • Eventide Asset Management's portfolio value fell 5.5% quarter-over-quarter to $6.05B.

Based on Eventide Asset Management's 13F filing for Q1 2026, filed 15 May 2026.